Pharma

As Pharma giant Roche continues its dive into the digital health realm, it is releasing a new self-testing device for INR or blood coagulation levels, that can wirelessly connect to a smartphone app.

The road to digital innovation in the pharma and healthcare space is going to take players across industries — from tech developers and engineers to researchers and clinicians, according to a panel of digital-focused VPs speaking at BIO 2018 in Boston.

Pharma companies are increasingly embracing the use of wearables and other connected devices to streamline and improve data collection in clinical trials.

Digital technologies are cementing their place across healthcare, and the pharmaceutical sector is no exception.

A drug no longer needs to be a tangible object, according to panelist at the BIO 2018 convention in Boston.

Stakeholders across healthcare are beginning to weigh the benefits and challenges digital therapeutics could bring to their businesses, and pharma is no exception.

When it comes to the challenges of raising an up-and-coming young company into a major player in its industry, former Apple and Pepsi CEO John Sculley is no spring chicken.

This week Blink Health, which makes an app and online tool for helping consumers find low prices for medications, filed a new legal claim against former partner MedImpact Healthcare System alleging greed and misconduct while describing the company as a “peddler of opioids.

Specialty pharmaceuticals are all different, but there’s one thing they have in common: they are difficult to prescribe.

Sanofi’s approach to digital health is broad, but focused, Rachel Sha, the company’s vice president of digital business development and licensing, told MobiHealthNews in an interview ahead of the upcoming BIO 2018 conference in Boston, where Sha will be speaking on a range of digital health-related topics.